Bal Pharma Limited

Bal Pharma Limitedverified

BALPHARMA.NS

Price:

$71.11

Market Cap:

$1.13B

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostrate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursuli...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2006-05-08

Stock Exchange

NSE

Ticker

BALPHARMA.NS

The PE Ratio as of December 2025 (TTM) for Bal Pharma Limited (BALPHARMA.NS) is 16.58

According to Bal Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is 16.58. This represents a change of -80.87% compared to the average of 86.66 of the last 4 quarters.

Bal Pharma Limited (BALPHARMA.NS) Historical PE Ratio (quarterly & annually)

How has BALPHARMA.NS PE Ratio performed in the past?

The mean historical PE Ratio of Bal Pharma Limited over the last ten years is 34.22. The current 16.58 PE Ratio has changed 4.75% with respect to the historical average. Over the past ten years (40 quarters), BALPHARMA.NS's PE Ratio was at its highest in in the September 2022 quarter at 320.39. The PE Ratio was at its lowest in in the March 2018 quarter at -84.00.

Quarterly (TTM)
Annual

Average

34.22

Median

27.53

Minimum

-3.70

Maximum

92.55

Bal Pharma Limited (BALPHARMA.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bal Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 293.88%

Maximum Annual PE Ratio = 92.55

Minimum Annual Increase = -534.54%

Minimum Annual PE Ratio = -3.70

Quarterly (TTM)
Annual
YearPE RatioChange
202518.16-7.34%
202419.60-52.10%
202340.9143.53%
202228.5077.26%
202116.08-534.54%
2020-3.70-113.93%
201926.56-35.78%
201841.36-33.49%
201762.19-32.81%
201692.55293.88%

Bal Pharma Limited (BALPHARMA.NS) Average PE Ratio

How has BALPHARMA.NS PE Ratio performed in the past?

The current PE Ratio of Bal Pharma Limited (BALPHARMA.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

26.22

5-year avg

24.65

10-year avg

34.22

Bal Pharma Limited (BALPHARMA.NS) PE Ratio vs. Peers

How is BALPHARMA.NS’s PE Ratio compared to its peers?

Bal Pharma Limited’s PE Ratio is greater than Par Drugs and Chemicals Limited (8.40), greater than Denis Chem Lab Limited (14.11), greater than Mangalam Drugs & Organics Limited (-4.18), greater than Mangalam Drugs & Organics Limited (-4.18), greater than Krebs Biochemicals & Industries Limited (-5.39), greater than Krebs Biochemicals & Industries Limited (-5.39), less than Achyut Healthcare Limited (282.34), less than Vaishali Pharma Limited (270.27), less than Fortis Malar Hospitals Limited (26.16), greater than Tyche Industries Limited (9.86),

Build a custom stock screener for Bal Pharma Limited (BALPHARMA.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bal Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bal Pharma Limited (BALPHARMA.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bal Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bal Pharma Limited's PE Ratio?

How is the PE Ratio calculated for Bal Pharma Limited (BALPHARMA.NS)?

What is the highest PE Ratio for Bal Pharma Limited (BALPHARMA.NS)?

What is the 3-year average PE Ratio for Bal Pharma Limited (BALPHARMA.NS)?

What is the 5-year average PE Ratio for Bal Pharma Limited (BALPHARMA.NS)?

How does the current PE Ratio for Bal Pharma Limited (BALPHARMA.NS) compare to its historical average?